Cargando…
Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients
Background and Aims: News strategies for the accurate assessment of the state of immunosuppression (IS) in liver transplant recipients are needed to prevent rejection and minimize drug-related side effects. miRNAs can potentially be used as diagnostic or prognostic biomarkers in transplant patients....
Autores principales: | Millán, Olga, Ruiz, Pablo, Orts, Lara, Ferré, Paula, Crespo, Gonzalo, Santana, Miguel, Fortuna, Virginia, Quintairos, Luís, Navasa, Miguel, Brunet, Mercè |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491707/ https://www.ncbi.nlm.nih.gov/pubmed/31068943 http://dx.doi.org/10.3389/fimmu.2019.00873 |
Ejemplares similares
-
Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients
por: Quintairos, Luis, et al.
Publicado: (2021) -
miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
por: Henriques, Daniel G., et al.
Publicado: (2023) -
Profiling Tissue and Biofluid miR-155-5p, miR-155(*), and miR-146a-5p Expression in Graft vs. Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2021) -
Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases
por: Ding, Han, et al.
Publicado: (2020) -
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
por: Simiene, Julija, et al.
Publicado: (2023)